Company Overview of AV Therapeutics, Inc.
AV Therapeutics, Inc. develops cancer therapeutics and immunotherapeutic vaccines. The company is developing Capridine, a chemotherapeutic drug that is in Phase I clinical trials used for the treatment of prostate and colon cancer; Provax for the treatment of prostate cancer; and infectious disease vaccines for small pox, anthrax, and tularemia. AV Therapeutics, Inc. was founded in 2011 and is based in White Plains, New York.
405 Tarrytown Road
White Plains, NY 10607
Founded in 2011
Key Executives for AV Therapeutics, Inc.
AV Therapeutics, Inc. does not have any Key Executives recorded.
AV Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact AV Therapeutics, Inc., please visit www.avth.net. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.